Cargando…

Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea

To compare mortality rate, the adjustment of case-mix variables is needed. The Pediatric Index of Mortality (PIM) 3 score is a widely used case-mix adjustment system of a pediatric intensive care unit (ICU), but there has been no validation study of it in Korea. We aim to validate the PIM3 in a Kore...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ok Jeong, Jung, Minyoung, Kim, Minji, Yang, Hae-Kyoung, Cho, Joongbum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220006/
https://www.ncbi.nlm.nih.gov/pubmed/28049251
http://dx.doi.org/10.3346/jkms.2017.32.2.365
_version_ 1782492549996347392
author Lee, Ok Jeong
Jung, Minyoung
Kim, Minji
Yang, Hae-Kyoung
Cho, Joongbum
author_facet Lee, Ok Jeong
Jung, Minyoung
Kim, Minji
Yang, Hae-Kyoung
Cho, Joongbum
author_sort Lee, Ok Jeong
collection PubMed
description To compare mortality rate, the adjustment of case-mix variables is needed. The Pediatric Index of Mortality (PIM) 3 score is a widely used case-mix adjustment system of a pediatric intensive care unit (ICU), but there has been no validation study of it in Korea. We aim to validate the PIM3 in a Korean pediatric ICU, and extend the validation of the score from those aged 0–16 to 0–18 years, as patients aged 16–18 years are admitted to pediatric ICU in Korea. A retrospective cohort study of 1,710 patients was conducted in a tertiary pediatric ICU. To validate the score, the discriminatory power was assessed by calculating the area under the receiver-operating characteristic (ROC) curve, and calibration was evaluated by the Hosmer-Lemeshow goodness-of-fit (GOF) test. The observed mortality rate was 8.47%, and the predicted mortality rate was 6.57%. For patients aged < 18 years, the discrimination was acceptable (c-index = 0.76) and the calibration was good, with a χ(2) of 9.4 in the GOF test (P = 0.313). The observed mortality rate in the hemato-oncological subgroup was high (18.73%), as compared to the predicted mortality rate (7.13%), and the discrimination was unacceptable (c-index = 0.66). In conclusion, the PIM3 performed well in a Korean pediatric ICU. However, the application of the PIM3 to a hemato-oncological subgroup needs to be cautioned. Further studies on the performance of PIM3 in pediatric patients in adult ICUs and pediatric ICUs of primary and secondary hospitals are needed.
format Online
Article
Text
id pubmed-5220006
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-52200062017-02-01 Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea Lee, Ok Jeong Jung, Minyoung Kim, Minji Yang, Hae-Kyoung Cho, Joongbum J Korean Med Sci Original Article To compare mortality rate, the adjustment of case-mix variables is needed. The Pediatric Index of Mortality (PIM) 3 score is a widely used case-mix adjustment system of a pediatric intensive care unit (ICU), but there has been no validation study of it in Korea. We aim to validate the PIM3 in a Korean pediatric ICU, and extend the validation of the score from those aged 0–16 to 0–18 years, as patients aged 16–18 years are admitted to pediatric ICU in Korea. A retrospective cohort study of 1,710 patients was conducted in a tertiary pediatric ICU. To validate the score, the discriminatory power was assessed by calculating the area under the receiver-operating characteristic (ROC) curve, and calibration was evaluated by the Hosmer-Lemeshow goodness-of-fit (GOF) test. The observed mortality rate was 8.47%, and the predicted mortality rate was 6.57%. For patients aged < 18 years, the discrimination was acceptable (c-index = 0.76) and the calibration was good, with a χ(2) of 9.4 in the GOF test (P = 0.313). The observed mortality rate in the hemato-oncological subgroup was high (18.73%), as compared to the predicted mortality rate (7.13%), and the discrimination was unacceptable (c-index = 0.66). In conclusion, the PIM3 performed well in a Korean pediatric ICU. However, the application of the PIM3 to a hemato-oncological subgroup needs to be cautioned. Further studies on the performance of PIM3 in pediatric patients in adult ICUs and pediatric ICUs of primary and secondary hospitals are needed. The Korean Academy of Medical Sciences 2017-02 2016-12-12 /pmc/articles/PMC5220006/ /pubmed/28049251 http://dx.doi.org/10.3346/jkms.2017.32.2.365 Text en © 2017 The Korean Academy of Medical Sciences. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Ok Jeong
Jung, Minyoung
Kim, Minji
Yang, Hae-Kyoung
Cho, Joongbum
Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea
title Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea
title_full Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea
title_fullStr Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea
title_full_unstemmed Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea
title_short Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea
title_sort validation of the pediatric index of mortality 3 in a single pediatric intensive care unit in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220006/
https://www.ncbi.nlm.nih.gov/pubmed/28049251
http://dx.doi.org/10.3346/jkms.2017.32.2.365
work_keys_str_mv AT leeokjeong validationofthepediatricindexofmortality3inasinglepediatricintensivecareunitinkorea
AT jungminyoung validationofthepediatricindexofmortality3inasinglepediatricintensivecareunitinkorea
AT kimminji validationofthepediatricindexofmortality3inasinglepediatricintensivecareunitinkorea
AT yanghaekyoung validationofthepediatricindexofmortality3inasinglepediatricintensivecareunitinkorea
AT chojoongbum validationofthepediatricindexofmortality3inasinglepediatricintensivecareunitinkorea